18F-fluorodeoxyglucose uptake on PET/computed tomography in association with androgen receptor expression and other clinicopathologic factors in surgically resected triple-negative breast cancer. Issue 1 (January 2021)
- Record Type:
- Journal Article
- Title:
- 18F-fluorodeoxyglucose uptake on PET/computed tomography in association with androgen receptor expression and other clinicopathologic factors in surgically resected triple-negative breast cancer. Issue 1 (January 2021)
- Main Title:
- 18F-fluorodeoxyglucose uptake on PET/computed tomography in association with androgen receptor expression and other clinicopathologic factors in surgically resected triple-negative breast cancer
- Authors:
- Lee, Hyo-jae
Lim, Hyo Soon
Ki, So Yeon
Park, Hye Mi
Lee, Jong Eun
Jeong, Won Gi
Shin, Sang Soo
Kwon, Seong Young
Park, Min Ho
Lee, Ji Shin - Abstract:
- Abstract : Objective: To evaluate whether androgen receptor expression in triple-negative breast cancer (TNBC) is associated with 18 F-fluorodeoxyglucose (FDG) uptake and to identify predictive factors of 18 F-FDG uptake in TNBC. Methods: We retrospectively assessed data of 156 surgically resected primary TNBC in 156 consecutive patients who underwent 18 F-FDG PET/computed tomography between July 2013 and May 2017. Clinicopathologic features, including androgen receptor expression, were categorized and the distribution of maximum standardized uptake value (SUVmax ) was compared between the groups. We also evaluated the correlations between the predictive factors and SUVmax . Results: Median SUVmax was higher in the androgen receptor-negative group than in the androgen receptor-positive group (8.8 vs. 7.1, P = 0.026) with negative correlation between androgen receptor and SUVmax ( P = 0.041, correlation coefficient ( r ) = –0.163). On multivariate regression analysis, tumor size (>20 mm), histological grade, Ki-67 (≥14%), and the presence of ductal carcinoma in situ (DCIS) were significantly associated with SUVmax ( P < 0.001, P = 0.012, P = 0.017 and P = 0.021, respectively). Tumor size, histological grade and Ki-67 were positively correlated with SUVmax ( P < 0.001, r = 0.450; P = 0.004, r = 0.228; P = 0.001, r = 0.269, respectively), while the presence of DCIS showed negative correlation with SUVmax ( P < 0.001, r = –0.292). Conclusion: AndrogenAbstract : Objective: To evaluate whether androgen receptor expression in triple-negative breast cancer (TNBC) is associated with 18 F-fluorodeoxyglucose (FDG) uptake and to identify predictive factors of 18 F-FDG uptake in TNBC. Methods: We retrospectively assessed data of 156 surgically resected primary TNBC in 156 consecutive patients who underwent 18 F-FDG PET/computed tomography between July 2013 and May 2017. Clinicopathologic features, including androgen receptor expression, were categorized and the distribution of maximum standardized uptake value (SUVmax ) was compared between the groups. We also evaluated the correlations between the predictive factors and SUVmax . Results: Median SUVmax was higher in the androgen receptor-negative group than in the androgen receptor-positive group (8.8 vs. 7.1, P = 0.026) with negative correlation between androgen receptor and SUVmax ( P = 0.041, correlation coefficient ( r ) = –0.163). On multivariate regression analysis, tumor size (>20 mm), histological grade, Ki-67 (≥14%), and the presence of ductal carcinoma in situ (DCIS) were significantly associated with SUVmax ( P < 0.001, P = 0.012, P = 0.017 and P = 0.021, respectively). Tumor size, histological grade and Ki-67 were positively correlated with SUVmax ( P < 0.001, r = 0.450; P = 0.004, r = 0.228; P = 0.001, r = 0.269, respectively), while the presence of DCIS showed negative correlation with SUVmax ( P < 0.001, r = –0.292). Conclusion: Androgen receptor-positive TNBC showed lower 18 F-FDG uptake than androgen receptor-negative triple-TNBC. Tumor size, histological grade, Ki-67 and the presence of DCIS significantly influenced 18 F-FDG uptake in TNBC. … (more)
- Is Part Of:
- Nuclear medicine communications. Volume 42:Issue 1(2021)
- Journal:
- Nuclear medicine communications
- Issue:
- Volume 42:Issue 1(2021)
- Issue Display:
- Volume 42, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 42
- Issue:
- 1
- Issue Sort Value:
- 2021-0042-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-01
- Subjects:
- androgen receptor -- PET -- standardized uptake value -- triple-negative breast neoplasm
Nuclear medicine -- Periodicals
616.07575 - Journal URLs:
- http://journals.lww.com/nuclearmedicinecomm/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
http://www.lww.com/Product/0143-3636 ↗ - DOI:
- 10.1097/MNM.0000000000001300 ↗
- Languages:
- English
- ISSNs:
- 0143-3636
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6180.923000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 21711.xml